Anti-CGRP monoclonal antibodies in the treatment of migraine in women: impact on menstrual relared migraine and algodysmenorrhea

• Autores principales: Anna V. Berdnikova (Autor), Natalya B. Kadymova (Autor), Nina V. Latysheva (Autor), Margarita V. Naprienko (Autor), Elena G. Filatova (Autor)
• Formato: Libro
• Publicado: LLC "MEDIAFORMAT", 2023-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background. Menstrual related migraine (MRM) occurs in 60% of women with migraine. These attacks are characterized by high intensity and poor response to abortive and prophylactic treatment. Hormonal therapy is one of the main treatment methods, but it has a large number of limitations. Increase in...